§ PHARMACEUTICALS
USD · Pharmaceuticals

TERN

TERNS PHARMACEUTICALS INC
USDSector · PharmaceuticalsBeta · -0.40
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

§ 04 · FUNDAMENTALS · THE BOOKS

P/B4.27EPS (TTM)-1.03
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.9.6M0.0%+17%
Morgan Stanley6.4M0.0%n/a
Avoro Capital Advisors LLC5.7M3.0%n/a
VANGUARD CAPITAL MANAGEMENT LLC4.4Mn/an/a
Holocene Advisors, LP4.1M0.5%+48%
Citadel Advisors3.2M0.0%+2%
◇ AC INTELLIGENCE

Top institutional owners for TERN as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER97.6% · 0 holders
OTHER1.4% · 239 holders
DEALER / BANK0.3% · 25 holders
QUALITY / COMPOUNDER0.2% · 24 holders
PASSIVE / INDEX0.2% · 9 holders
TACTICAL / MACRO0.2% · 6 holders
SYSTEMATIC / QUANT0.0% · 9 holders
INCOME / DEFENSIVE0.0% · 13 holders
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for TERN in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES